Irrimax Corporation is a wholly owned subsidiary of Innovation Technologies, Inc. Innovation Technologies holds the rights to US and worldwide patents that provide broad protection for the use of low concentration CHG (less than 1%) technology. Irrimax Corporation develops, manufactures and markets two products: Irrisept®, a wound debridement and cleansing system that contains 0.05% Chlorhexidine Gluconate (CHG) in sterile water for irrigation; and Irrimax®, Wound Irrigation System (0.9% Normal Saline).

If you are a current investor and need to contact the company, please email: or call +1 770.807.3355

Print Friendly, PDF & Email